Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
24009 | Asengeprast (FT011) | 1001288-58-9 | ≧98.0% | |
Asengeprast (FT011) is an anti-fibrotic agent thatreduces mRNA expression of collagen | ||||
20648 | AZD7986 | 1802148-05-5 | 98% Min. | |
Brensocatib, also known as AZD7986, INS 1007, is an oral reversible inhibitor of dipe | ||||
20638 | ATH434 mesylate | 2387898-69-1 | ≧98.0% | |
ATH434, is an oral agent designed to inhibit the aggregation of pathological proteins | ||||
20617 | Adrixetinib | 2394874-66-7 | 98% Min. | |
Adrixetinib is a tyrosine kinase inhibitor with potential use as an antineoplastic ag | ||||
20616 | Alpibectir | 2285440-39-1 | 98% Min. | |
Alpibectir is an antibacterial agent. | ||||
20609 | ARV-471 | 2229711-68-4 | 98% Min. | |
20574 | ABI-231 | 1332881-26-1(free base) | 98% Min. | |
ABI-231 is a potent, orally bioavailable tubulin inhibitor that interacts with the co | ||||
20563 | 1,1'-Azobis(formamide) | 123-77-3 | 98% Min. | |
1,1'-Azobis(formamide) has been shown to have the ability to induce asthma and sk | ||||
20552 | Adaptaquin | 385786-48-1 | 98% Min. | |
Adaptaquin is a hydroxyquinoline inhibitor of HIF-PHD enzymes. Adaptaquin reduces neu | ||||
20540 | Atrasentan | 173937-91-2 | 98% Min. | |
Atrasentan, also known as ABT-627, is a orally available ETA receptor antagonist with | ||||
20535 | Arazasetron | 2025360-90-9 | 98% Min. | |
Arazasetron is an antiemetic which acts as a 5-HT3 receptor antagonist, pKi = 9.27. | ||||
20532 | AZD4747 | 98% Min. | ||
AZD4747 is a Potent and Selective Inhibitor of Mutant GTPase KRASG12C with Demonstrab | ||||
20515 | 3-AMINO-3-(4-CHLOROPHENYL)PROPIONIC ACID | 19947-39-8 | 98% Min. | |
20508 | AZD5991 | 2143061-81-6 | ≧98.0% | |
AZD5991 is a potent and selective Mcl-1 inhibitor for treatment of hematologic cancer | ||||
20507 | ASLAN003 | 1035688-66-4 | 98% Min. | |
ASLAN003 is an orally active and potent inhibitor of DHODH (Human Dihydroorotate Dehy | ||||
237072 | AZD0095 | 2750001-23-9 | ≧98.0% | |
AZD0095 is a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. | ||||
20502 | Alentemol HBr | 112892-51-0 | 98% Min. | |
Alentemol, also known as U-66444B and alentamol, is a selective dopamine autoreceptor | ||||
20501 | Alfacalcidol | 41294-56-8 | 98% Min. | |
Alfacalcidol is an active metabolite of Vitamin D, which performs important functions | ||||
20490 | AG-7404 | 343565-99-1 | 98% Min. | |
AG-7404 is a potent protease inhibitor with Anti-poliovirus activity. AG-7404 was act | ||||
20476 | AZD5718 | 2041075-86-7 | 98% Min. | |
AZD5718 is a novel Inhibitor of 5-Lipoxygenase Activating Protein(FLAP) for Treatment | ||||
20450 | ALZ-801 | 1034190-08-3 | 98% Min. | |
ALZ-801 is an oral, small-molecule inhibitor of beta amyloid (Aβ) oligomer formation | ||||
20440 | AZD-2207 | 866598-45-0 | 98% Min. | |
AZD-2207 is a cannabinoid receptor CB1 antagonist and highly lipophilic compound for | ||||
20439 | AZD6703 | 851845-37-9 | 98% Min. | |
AZD6703 is a potent, selective and reversible orally bioavailable inhibitor of p38 mi | ||||
20429 | Afizagabar | 1398496-82-6 | 98% Min. | |
Afizagabar, also known as S44819 and Egis 13529, is a GABA receptor antagonist. | ||||
20427 | AMD 070 | 558447-26-0 | 98% Min. | |
171453 | 1-(6-aminopyridin-2-yl)ethanone | 1060801-23-1 | ≧98.0% | |
1-(6-aminopyridin-2-yl)ethanone, CAS 1060801-23-1. | ||||
171553 | Anle138b | 882697-00-9 | ≧98.0% | |
Anle138b is an oral, brain-penetrant, general inhibitor of protein aggregation. It wa | ||||
20425 | 5-AMino-3-broMo-2-Morpholinopyridine | 1215932-56-1 | 98% Min. | |
20424 | 2-Amino-5-bromo-4-methoxy-3-pyridinecarbonitrile | 951884-75-6 | 98% Min. | |
20421 | 4-AMINO-6-IODOPYRIMIDINE | 53557-69-0 | 98% Min. | |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1